Literature DB >> 12858187

Development of a novel non-human primate model for preclinical gene vector safety studies. Determining the effects of intracerebral HSV-1 inoculation in the common marmoset: a comparative study.

T S Deisboeck1, H Wakimoto, U Nestler, D N Louis, P K Sehgal, M Simon, E A Chiocca, F H Hochberg.   

Abstract

The owl monkey (Aotus trivirgatus) has served as the standard non-human primate model of herpes simplex virus-1 (HSV-1) infection because it is highly susceptible to HSV-1 encephalitis. Owl monkeys, however, are expensive, difficult to obtain, and difficult to maintain in captivity, thus greatly hampering the efficiency of preclinical gene therapy trials for brain tumors using HSV-1-based vectors. We have therefore compared the susceptibility of the common marmoset (Callithrix jacchus) with the owl monkey in a model of intracerebral inoculation of wildtype HSV-1 F-strain at increasing titers. The common marmosets consistently succumbed earlier to viral encephalitis than the owl monkeys. The histological evaluation of the common marmoset revealed extensive HSV-1 infection with a concomitant yet less marked inflammatory response compared to the owl monkeys. PCR for HSV-1 demonstrated a similar extra-CNS shedding route in both experimental models. Our findings show that the common marmoset is at least as susceptible to intracerebral HSV-infection as the owl monkey and that it can therefore serve as a valid and reliable experimental model for the important preclinical safety tests of HSV-based therapeutic viral vector constructs in the brain.

Entities:  

Mesh:

Year:  2003        PMID: 12858187     DOI: 10.1038/sj.gt.3302003

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  5 in total

1.  A model of genital herpes simplex virus Type 1 infection in Rhesus Macaques.

Authors:  Meropi Aravantinou; Ines Frank; Geraldine Arrode-Bruses; Moriah Szpara; Brooke Grasperge; James Blanchard; Agegnehu Gettie; Nina Derby; Elena Martinelli
Journal:  J Med Primatol       Date:  2017-08       Impact factor: 0.667

2.  Safety and biodistribution studies of an HSV multigene vector following intracranial delivery to non-human primates.

Authors:  D Wolfe; A Niranjan; A Trichel; C Wiley; A Ozuer; E Kanal; D Kondziolka; D Krisky; J Goss; N Deluca; M Murphey-Corb; J C Glorioso
Journal:  Gene Ther       Date:  2004-12       Impact factor: 5.250

3.  Experimental Oral Herpes Simplex Virus-1 (HSV-1) Co-infection in Simian Immunodeficiency Virus (SIV)-Infected Rhesus Macaques.

Authors:  Meropi Aravantinou; Olga Mizenina; Giulia Calenda; Jessica Kenney; Ines Frank; Jeffrey D Lifson; Moriah Szpara; Lichen Jing; David M Koelle; Natalia Teleshova; Brooke Grasperge; James Blanchard; Agegnehu Gettie; Elena Martinelli; Nina Derby
Journal:  Front Microbiol       Date:  2017-12-05       Impact factor: 5.640

4.  The Characteristics of Herpes Simplex Virus Type 1 Infection in Rhesus Macaques and the Associated Pathological Features.

Authors:  Shengtao Fan; Hongzhi Cai; Xingli Xu; Min Feng; Lichun Wang; Yun Liao; Ying Zhang; Zhanlong He; Fengmei Yang; Wenhai Yu; Jingjing Wang; Jumin Zhou; Qihan Li
Journal:  Viruses       Date:  2017-01-30       Impact factor: 5.048

Review 5.  Animal models for target diseases in gene therapy--using DNA and siRNA delivery strategies.

Authors:  Ian S Blagbrough; Chiara Zara
Journal:  Pharm Res       Date:  2008-10-08       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.